BEDFORD, Mass.--(BUSINESS WIRE)--ConforMIS, Inc., a medical technology company providing customized total knee replacement implants for patients, today announced a new generation of the company’s iTotal® CR (cruciate-retaining) total knee replacement. The new generation iTotal CR was designed to improve procedural efficiency by further reducing the number of intraoperative steps required during a knee replacement surgery. The company will demonstrate the latest generation iTotal CR at the American Academy of Orthopaedic Surgeons (AAOS) meeting in Las Vegas, March 25-27, 2015.
ConforMIS’ iTotal CR is the only individually sized and shaped, or customized, total knee replacement product available today that is designed and manufactured specifically to match each patient’s unique anatomy. In clinical studies, the iTotal CR customized implant has demonstrated greater patient satisfaction, greater stability and more natural kinematics compared to traditional, off-the-shelf knee implants.
“ConforMIS is setting a new pace for innovation,” said Philipp Lang, MD, CEO of ConforMIS. “The latest generation iTotal again demonstrates our ability to respond to the needs of our customers with better solutions for patients, surgeons and hospitals. Our scalable business model differentiates our company and allows us the agility and speed to bring new technology to patients rapidly.”
About ConforMIS, Inc.
ConforMIS is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient’s unique anatomy. ConforMIS offers a broad line of customized knee implants designed to restore the natural shape of a patient’s knee. In recent clinical studies, iTotal CR®, ConforMIS’ cruciate-retaining total knee replacement implant and best-selling product, demonstrated superior clinical outcomes, including better function and greater patient satisfaction compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 470 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints and other elements of the iFit® Image-to-Implant® technology platform. ConforMIS believes its iFit® Image-to-Implant® technology platform has application to other major joints in the worldwide market for joint replacement products. For more information visit www.conformis.com.
